| Literature DB >> 34349461 |
Raed I Felimban1,2, Samaha M Sumeda3.
Abstract
CONTEXT: Kell blood group system is considered as the third clinically significant blood group in blood transfusion due to the highly immunogenetic of their antigens. No data are available regarding the frequencies of the Kell blood group antigens in Jeddah city. Knowledge of the antigen and phenotype frequencies is crucial to assess the risk of alloimmunization and to guide the probability of finding antigen-negative donor blood, which can be useful when blood transfusion is required for a patient who has multiple red cell alloantibodies. AIMS: The aim of this study was to determine the distribution of Kell blood group: K, k, Kpa, and Kpb antigens and phenotypes among blood donors in Jeddah city, western Saudi Arabia, to improve the transfusion services in the area. SUBJECTS AND METHODS: Seven hundred and fifty-eight blood samples from blood donors were used in the study. The samples were collected from different national blood bank centers in Jeddah city hospitals. Kell antigens were typed through gel card method using commercial antisera. STATISTICAL ANALYSIS USED: The gathered data were analyzed using the SPSS program. Frequency and crosstab tests were completed to achieve the objectives of the current study.Entities:
Keywords: Blood group; Kell antigen; distribution; phenotypes; transfusion
Year: 2021 PMID: 34349461 PMCID: PMC8294449 DOI: 10.4103/ajts.AJTS_109_19
Source DB: PubMed Journal: Asian J Transfus Sci ISSN: 0973-6247
Frequency of Kell antigens and phenotypes among donors
| Frequency ( | Gender ( | Nationality ( | |||
|---|---|---|---|---|---|
| Male, | Female, | Saudi, | Non-Saudi, | ||
| Antigens | |||||
| K+ | 93 (12.3) | 93 (12.5) | 0 | 74 (16.3) | 19 (6.3) |
| K− | 665 (87.7) | 652 (87.5) | 13 (100) | 380 (83.7) | 285 (93.8) |
| k+ | 751 (99.1) | 738 (99.1) | 13 (100) | 447 (98.5) | 304 (100) |
| k− | 7 (0.9) | 7 (0.94) | 0 | 7 (1.5) | 0 |
| Kpa+ | 20 (2.6) | 20 (2.7) | 0 | 18 (4.0) | 2 (0.7) |
| Kpa− | 738 (97.4) | 725 (97.3) | 13 (100) | 436 (96) | 302 (99.3) |
| Kpb+ | 758 (100) | 745 (100) | 13 (100) | 454 (100) | 304 (100) |
| Kpb− | 0 | 0 | 0 | 0 | 0 |
| Phenotypes | |||||
| K-k+ | 665 (87.8) | 652 (87.5) | 13 (100) | 380 (83.7) | 285 (62.8) |
| K+k+ | 86 (11.3) | 86 (11.5) | 0 | 67 (14.8) | 19 (6.3) |
| K+k− | 7 (0.92) | 7 (0.94) | 0 | 7 (1.5) | 0 |
| K−k− | 0 | 0 | 0 | 0 | 0 |
| Kp(a+b+) | 20 (2.6) | 20 (2.7) | 0 | 18 (4.0) | 2 (0.66) |
| Kp(a−b+) | 738 (97.3) | 725 (97.3) | 13 (100) | 436 (96.0) | 302 (66.5) |
| Kp(a+b−) | 0 | 0 | 0 | 0 | 0 |
| Kp(a−b−) | 0 | 0 | 0 | 0 | 0 |
Antigen and phenotype frequencies of Kell blood group system (compared to other studies in Saudi Arabia and the rest of the world)
| Studies | Total Sample ( | Antigens (%) | Phenotypes (%) | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| K+ | K− | K+ | K− | Kpa+ | Kpa− | Kpb+ | Kpb− | K−k+ | K+k+ | K+k− | K−k− | Kp (a+b+) | Kp (a−b+) | Kp (a+b−) | Kp (a−b−) | ||
| Present study, (2018) Jeddah | 758 | 12.3 | 87.7 | 99.1 | 0.9 | 2.6 | 97.4 | 100 | 0 | 87.7 | 11.3 | 0.9 | 0 | 2.6 | 97.3 | 0 | 0 |
| Elsayid [ | 400 | 18.2 | 81.2 | 97 | 3 | 11.7 | 88.3 | 96 | 4 | 81.5 | 15.5 | 3 | 0 | 7.8 | 88 | 4.2 | 0 |
| Owaidah | 100 | 8 | 92 | 100 | 0 | 0 | 100 | 100 | 0 | 92 | 8 | 0 | 0 | 0 | 100 | 0 | 0 |
| Azarkeivan [ | 11,557 | 3.8 | 96.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Siransy | 651 | 0.77 | - | 98.1 | - | 0.61 | - | 82.8 | - | 98.9 | - | - | - | - | - | - | - |
| Vasquez [ | 200 | 4 | 96 | 99.5 | 0.5 | - | - | - | - | 96 | 3.5 | 0.5 | 0 | - | - | - | - |
| Hamed | 2094 | White 2.96 Black 1.3 | White 97.0 Black 98.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Thakral | 1240 | 5.56 | 94.4 | 100 | 0 | 0.95 | 99.1 | 100 | 0 | 94.3 | 5.6 | 0 | 0 | 0.95 | 99.1 | 0 | - |
| Makroo | 3073 | 3.5 | 96.5 | 99.9 | 0.03 | - | - | - | - | 96.5 | 3.5 | 0.03 | 0 | - | - | - | - |
| Rani | 2000 | 3.5 | 96.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Karim | 100 | 0 | 100 | 100 | 0 | - | - | - | - | 100 | 0 | 0 | 0 | - | - | - | - |
| Yu | 1412 | 0.14 | 99.8 | 100 | 0 | 0.28 | 99.7 | 100 | 0 | 99.8 | 0.14 | 0 | 0 | 0.28 | 99.7 | 0 | 0 |
| Adewoyin | 302 | 0 | 100 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Kahar and Patel [ | 115 | 6.09 | 93.9 | 100 | 0 | 1.74 | 98.3 | 100 | 0 | 93.9 | 6.09 | 0 | - | 1.74 | 98.3 | - | - |
| Keramati | 522 | - | - | - | - | - | - | - | - | 92 | 5.7 | 2.3 | - | 6 | 90.7 | 3.3 | - |
| Agarwal | 9280 | - | - | - | - | - | - | - | - | 98.0 | 1.97 | 0 | 0 | - | - | - | - |
| Al-Riyami | 337 | 4.5 | - | 99.4 | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Shah | 200 | 2.5 | - | 100 | - | - | - | - | - | - | - | - | - | 1 | - | - | - |